Biomarker-driven treatment for muscle-invasive bladder cancer (MIBC) led to a 2-year metastasis-free survival (MFS) rate that ...

In 2022, over 600,000 people across the world were diagnosed with bladder cancer, a 7.1% increase from 2020, putting their ...

The research team designed a new diagnostic kit that detects bladder cancer biomarkers by utilizing the principle of layering ...

Roberto Salgado, MD, anatomic pathologist for breast cancer translational research at Institut Jules Bordet, examines the significance of tumor-infiltrating lymphocytes (TILs) in various breast cancer ...

Why are women screened for breast cancer while men are ignored? The old arguments no longer stack up, say experts ...

Bladder cancer affects the body’s ability to urinate and can inflict pain. Healthcare professionals understand what causes this disease, though researchers are finding new causes. What are the latest ...

DIETARY changes such as taking fish oil supplements may help reduce cancer cell growth, according to a new study. The researchers described it as “an important step toward understanding how ...

Bladder cancer is one of the most common types of cancer, particularly among older adults. While genetics and age play a role, lifestyle factors can significantly impact your risk. Making natural, ...

This review aims to present current evidence on the use of miRNA as biomarkers for the non-invasive diagnosis of bladder cancer. Methods: A systematic literature review, using the Medline database, ...

Cell-free DNA (cfDNA) is one of the important biomarkers of liquid biopsy for many malignant cancers like urothelial bladder cancer. However, the use of cfDNA in upper tract urothelial carcinoma ...

Emerging urinary biomarkers offer promise in identifying tumors non-invasively, but their high costs currently limit widespread use. Early detection is crucial in bladder cancer management.